News and Events

Leadership Q&A: NIH to bolster RECOVER Long COVID research efforts

Gary Gibbons, M.D., Walter Koroshetz, M.D., and Jeanne Marrazzo, M.D., M.P.H. of the NIH answer questions about investing an additional $515 million in RECOVER's Long COVID research efforts.

NIH to bolster RECOVER Long COVID research efforts through infusion of $515 million

This additional funding will build on and continue RECOVER's work to improve our understanding of and ability to diagnose, prevent, and treat Long COVID.

Now Available: Dataset for “Development of a Definition of Postacute Sequelae of SARS-CoV-2 Infection”

Authorized researchers may request access to the dataset, which contains more than 3.3 million de-identified data entries and a Data Dictionary.

RECOVER Research Q&A: RECOVER “First Look” Adult Cohort Study

Find answers to some of the most frequently asked questions (FAQs) about the first findings from RECOVER's research on Long COVID in adults.

Large study provides scientists with deeper insight into Long COVID symptoms

RECOVER researchers have identified the 12 symptoms that are most likely to be experienced by adults with Long COVID.

NIH Director’s blog: What Clinical Research Comes Next for Helping People with Long COVID

Three leaders at the NIH explain how patient experiences have guided and will continue to guide RECOVER's efforts to understand, diagnose, prevent, and treat Long COVID.

RECOVER Adult Study Protocol Available

This publication describes the study plan RECOVER researchers follow when answering questions about how Long COVID affects people aged 18 years and older.

NIH Builds Large Nationwide Study Population of Tens of Thousands to Support Research on Long-term Effects of COVID-19

$470 million in funding will support new studies of large groups of people (called cohorts) and expand existing cohort studies to include a focus on Long COVID.